ImmunityBio (IBRX) announced U.S. Urology Partners, one of the nation’s largest independent providers of urology and related specialty ...

ISG beats Q4 2024 estimates, shifts focus to growth in Americas & AI. Improved margins, cost cuts, and strategic shifts ...

Indigo stock price has given a fresh breakout from a Symmetrical Triangle on daily charts and a role reversal is on the cards as the previous hurdle zones can now be seen as support levels. Traders ...

ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an alternative source of Bacillus Calmette-Guerin (BCG) to treat bladder cancer.

In a recent Sermo survey of 100 U.S. urologists, 57 percent indicated they were unable to treat patients in the last 12 months due to a lack of access to TICE ® BCG. The alternative BCG source ...

The authorization was granted to ImmunityBio, the manufacturer of Anktiva ® (nogapendekin alfa inbakicept-pmln), an interleukin-15 receptor agonist, indicated with BCG for adult patients with BCG ...

The Official Trending Chart is based on the first four sales days of each chart week (that's Friday to Monday) and ranks those songs showing week-on-week growth on the Official Top 100 Singles ...

17:18 EST Binah Capital Group Inc (BCG) files to sell 21.33M shares of common stock for holders Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing ...

The exhibition, spanning over 20,000 square metres, features seven zones: Innovation Showcase, BCG & Climate Change, Future Trend, Start-Up Pitching, Business Matching, Awards, and FTI Outlet. A ...

A new report released today, January 22, from Nasdaq and Boston Consulting Group (BCG), suggests that by embracing a systems-based approach powered by modern technologies like artificial ...